<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> is associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> but whether it causes <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0004943'>accelerated atherosclerosis</z:hpo> or an epiphenomena of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is not clear </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-eight young normoglycemic, non-<z:mp ids='MP_0001261'>obese</z:mp>, first degree relatives of type 2 diabetic subjects (FH(+)) and 38 control subjects without family history of <z:mp ids='MP_0002055'>diabetes</z:mp> (FH(-)) (age and sex matched), were studied to determine difference in inflammatory markers, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin (fasting and 2h after 75gm oral <z:chebi fb="105" ids="17234">glucose</z:chebi>) <z:chebi fb="23" ids="18059">lipids</z:chebi> and serum levels of C-reactive protein (CRP), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha and fibrinogen were measured after an overnight fast of 10-12h </plain></SENT>
<SENT sid="3" pm="."><plain>First degree relative group (FH(+)) have higher BMI (p&lt;0.05), composite <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (p&lt;0.05) and CRP level (p&lt;0.05), however, after adjustment for BMI, the two groups did not significantly differ </plain></SENT>
<SENT sid="4" pm="."><plain>Fibrinogen was not significantly correlated with composite <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in FH(+) group after controlling with BMI </plain></SENT>
<SENT sid="5" pm="."><plain>In FH(+) group composite <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was significantly correlated with systolic blood pressure (p&lt;0.05), <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> (p&lt;0.05), postprandial insulin level (p&lt;0.05) and HOMA-IR (p&lt;0.05) after adjustment of BMI </plain></SENT>
<SENT sid="6" pm="."><plain>Thus <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is a major determinant of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in subjects with high risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> showing the strong relationship between <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
</text></document>